Comparison Bright Minds Biosciences (DRUG) with Competitors
Bright Minds Biosciences (DRUG) industry is Biotechnology.
Debt-to-Equity
DRUG0.03%
Industry28.27%
Upside-99.91%
Free Cash Flow Yield
DRUG-2.00%
Industry-1.75%
Upside-0.25%
P/E
DRUG-30.85
Industry-20.52
Upside-1033.68%
P/B
DRUG3.34
Industry5.15
Upside-35.07%